NAB-PACLITAXEL
Clinical trials for NAB-PACLITAXEL explained in plain language.
Never miss a new study
Get alerted when new NAB-PACLITAXEL trials appear
Sign up with your email to follow new studies for NAB-PACLITAXEL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo combo could shrink breast tumors before surgery
Disease control Recruiting nowThis study tests two different chemotherapy combinations given before surgery for people with triple-negative breast cancer. The goal is to see which combo works better at shrinking tumors, making surgery easier and more effective. About 520 participants will be randomly assigned…
Matched conditions: NAB-PACLITAXEL
Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated May 16, 2026 23:33 UTC
-
New hope for aggressive breast cancer: chemo combo trial underway
Disease control Recruiting nowThis study tests two different chemotherapy drug combinations in people with advanced triple-negative breast cancer, a fast-growing type. The goal is to see which combo works better at controlling the disease and extending life. Participants will receive either nab-paclitaxel plu…
Matched conditions: NAB-PACLITAXEL
Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated May 16, 2026 23:33 UTC
-
Kidney-Sparing drug combo offers hope for renal pelvic cancer patients
Disease control Recruiting nowThis study tests a combination of two drugs (tislelizumab and nab-paclitaxel) to treat a type of kidney cancer called renal pelvic cancer. The goal is to control the disease while saving the kidney, avoiding the need for full kidney removal. About 35 adults with early-stage cance…
Matched conditions: NAB-PACLITAXEL
Phase: PHASE2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated May 12, 2026 13:41 UTC